Really proud to be a part of this exciting work elucidating a key driver of GBM immunotherapy-resistance! @BillyTomski@Dukeneurosurg@DukeHealth check it out!
Thrilled to announce alphagenome-pytorch, an accurate, readable, and careful port of AlphaGenome's architecture and weights to PyTorch. Work with @gtcaa@m_kjellberg@chriswzou@tuxinming as part of the GenomicsxAI initiative between @anshulkundaje and @pkoo562 labs.
(1/15) My thesis work is out in @NatureComms (https://t.co/B7s7zlC1sM)!
We found that neuronal CaMKK2 causes checkpoint blockade resistance and reduces survival in preclinical glioblastoma (GBM), indicating that CaMKK2 may be a therapeutic target in #GBM.